HCA Healthcare's (HCA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Key Points

• Cantor Fitzgerald has reaffirmed an "overweight" rating for HCA Healthcare, setting a price target of $444.00, suggesting a potential upside of 2.34% from its previous close.
• HCA Healthcare reported $6.84 earnings per share in its latest earnings, surpassing analysts' expectations, with quarterly revenue reaching $18.61 billion.
• Analysts have mixed ratings on HCA Healthcare, with one Strong Buy, eight Buy, nine Hold, and a consensus target price of $410.83.

HCA Healthcare (NYSE:HCA - Get Free Report)'s stock had its "overweight" rating reissued by Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $444.00 price target on the stock. Cantor Fitzgerald's price target would indicate a potential upside of 2.34% from the stock's previous close.

Several other analysts have also recently weighed in on the stock. Weiss Ratings reiterated a "buy (b-)" rating on shares of HCA Healthcare in a report on Saturday, September 27th. Bank of America lifted their price target on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a research report on Wednesday, September 10th. JPMorgan Chase & Co. increased their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Finally, Barclays raised their target price on HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a research report on Thursday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $410.83.

HCA Healthcare Trading Up 1.0%

Shares of HCA Healthcare stock opened at $433.83 on Tuesday. The firm has a market capitalization of $101.51 billion, a PE ratio of 18.24, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40. The business's 50-day moving average price is $399.40 and its 200-day moving average price is $373.65. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $435.03.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts predict that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.30% of the company's stock.

Institutional Trading of HCA Healthcare

Large investors have recently made changes to their positions in the business. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $26,000. Saudi Central Bank bought a new stake in HCA Healthcare in the first quarter worth about $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare in the first quarter worth approximately $27,000. Ameriflex Group Inc. bought a new position in HCA Healthcare in the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare during the second quarter valued at $27,000. 62.73% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.